Tag Archives: Department of Chemistry: University of Aberdeen

Another Recent Alzheimer’s Disease Drug Trial Disappointment (Lancet)

Posted on November 24, 2016 by Dementia and Elderly Care News

Summary Researchers aimed to discover whether LMTM [Leuco-methylthioninium bis(hydromethanesulfonate] might be safe and effective for slowing disease progression in patients with mild to moderate Alzheimer’s Disease. LMTM had previously been found to work as a selective inhibitor of tau protein … Continue reading →

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Pharmacological Treatments, Quick Insights | Tagged Aberdeen Biomedical Imaging Centre: University of Aberdeen, Abnormal Proteins (Tau), Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog), Alzheimer's Disease Co-operative Study-Activities of Daily Living Inventory (ADCS-ADL) Scale, Alzheimer's Disease Research Unit, BioClinica (Lyon France), Canada, Clinicaltrials No. NCT01689246, CSD Biostatistics (USA), Department of Chemistry: University of Aberdeen, Department of Neurology: University of Southern California, Department of Neurosciences: University of California, Department of Psychiatry and Behavioral Sciences: University of Southern California, Douglas Mental Health University Institute (Montreal), Drug Trials, Drug Trials Failure Rate, European Union Clinical Trials Registry No. 2012-002866-11, France, Institute for Complex Systems and Mathematical Biology: University of Aberdeen, Keck School of Medicine: University of Southern California, Lancet, Leonard Davis School of Gerontology: University of Southern California, Leuco-Methylthioninium (LMTM), Leuco-Methylthioninium Bis(Hydromethanesulfonate): LMTM, McGill Centre for Studies in Aging, Medical Sciences and Nutrition: University of Aberdeen, Methaemoglobinaemia, Methylthioninium Chloride, Mild Alzheimer’s Disease, Misfolded Proteins, Moebius-Consult (Baar Switzerland), Nuffield Department of Clinical Neurosciences: University of Oxford, RadMD (USA), Reasons for Termination of Trials, Salamandra LLC (USA), School of Medicine: University of Aberdeen, School of Medicine: University of California, Switzerland, Tau, Tau Aggregation, Tau Aggregation Inhibitors, Tau Pathology, Tau Protein, Tau Tangles, Tau-Targeting Drugs, TauRx Therapeutics (Aberdeen), United States, University Hospitals and University of Geneva, University of Aberdeen, University of California, University of Oxford, University of Southern California, USA

Tag Archives: Department of Chemistry: University of Aberdeen

Another Recent Alzheimer’s Disease Drug Trial Disappointment (Lancet)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites